Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $582.86 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $395.22 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $135.73 | 2 | $0 (2022) |
| ABBVIE INC. | $51.91 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $394.60 | 6 | Amgen Inc. ($363.81) |
| 2023 | $52.53 | 3 | Amgen Inc. ($31.41) |
| 2022 | $135.73 | 2 | Janssen Pharmaceuticals, Inc ($135.73) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: Inflammation | ||||||
| 03/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $96.63 | General |
| Category: Inflammation | ||||||
| 02/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 02/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 12/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Inflammation | ||||||
| 11/28/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Bone Health | ||||||
| 10/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $118.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 46 | 1,684 | 2,073 | $165,819 | $69,279 |
| 2022 | 46 | 1,610 | 1,953 | $129,338 | $58,933 |
| 2021 | 62 | 2,710 | 4,194 | $177,697 | $88,586 |
| 2020 | 60 | 3,242 | 4,014 | $162,733 | $68,382 |
All Medicare Procedures & Services
214 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 264 | $52,272 | $19,685 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 185 | 261 | $36,801 | $13,668 | 37.1% |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | Office | 2023 | 44 | 48 | $8,880 | $6,709 | 75.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 48 | 48 | $9,696 | $5,130 | 52.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 21 | $9,009 | $3,651 | 40.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 20 | $6,360 | $2,570 | 40.4% |
| 87486 | Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | Office | 2023 | 44 | 48 | $2,160 | $1,651 | 76.4% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 44 | 48 | $2,160 | $1,651 | 76.4% |
| 87581 | Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | Office | 2023 | 43 | 47 | $2,115 | $1,616 | 76.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 61 | 72 | $2,376 | $745.20 | 31.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 18 | 18 | $2,304 | $728.10 | 31.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 80 | 97 | $794.00 | $703.92 | 88.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 67 | 78 | $3,120 | $667.44 | 21.4% |
| 82172 | Apolipoprotein level | Office | 2023 | 15 | 32 | $1,120 | $661.44 | 59.1% |
| 84681 | C-peptide (protein) level | Office | 2023 | 30 | 31 | $1,426 | $632.09 | 44.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 42 | 42 | $1,218 | $631.68 | 51.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 40 | 40 | $1,120 | $601.60 | 53.7% |
| 82985 | Glycated protein level | Office | 2023 | 31 | 32 | $1,152 | $525.44 | 45.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,232 | $506.71 | 41.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 16 | 16 | $1,472 | $464.16 | 31.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 27 | 28 | $1,484 | $460.88 | 31.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 54 | 60 | $1,440 | $456.60 | 31.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 23 | 24 | $1,176 | $398.40 | 33.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $455.00 | $393.12 | 86.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $1,100 | $380.82 | 34.6% |
About Sabrina Graham, ARNP
Sabrina Graham, ARNP is a Family healthcare provider based in Belleview, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2015. The National Provider Identifier (NPI) number assigned to this provider is 1114397486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sabrina Graham, ARNP has received a total of $582.86 in payments from pharmaceutical and medical device companies, with $394.60 received in 2024. These payments were reported across 11 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($582.86).
As a Medicare-enrolled provider, Graham has provided services to 9,246 Medicare beneficiaries, totaling 12,234 services with total Medicare billing of $285,180. Data is available for 4 years (2020–2023), covering 214 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Belleview, FL
- Active Since 09/30/2015
- Last Updated 04/04/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1114397486
Products in Payments
- Repatha (Biological) $249.98
- XARELTO (Drug) $135.73
- Otezla (Drug) $131.93
- VRAYLAR (Drug) $51.91
- EVENITY (Biological) $13.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Belleview
Allison Brewer-Reed, Arnp, ARNP
Family — Payments: $8,807
Carolyn Macias, Msn Aprn Fnp Bc, MSN APRN FNP BC
Family — Payments: $1,385
Gregory Aguila
Family — Payments: $1,195
Regina Dubois-Rodabaugh
Family — Payments: $972.08
Tracy Riddle, Arnp-C, ARNP-C
Family — Payments: $536.65
Yohena Hernandez-Clemente, Aprn, APRN
Family — Payments: $381.67